Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)

Ichiro Nakamura; Hiroshi Maegawa; Kazuyuki Tobe; Satoshi Uno

doi:10.1007/s13300-021-01134-7

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)

Ichiro Nakamura^*, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

^*Corresponding author for this work

Faculty of Medicine

Research output: Contribution to journal › Comment/debate

Abstract

In the original article, ADR data from STELLAELDER are provided for Table 3 incorrectly which is originally for Table 2. RESULTS Safety Original ADR data from STELLA-ELDER are provided in Table 3 for comparison [9]. Corrected ADR data from STELLA-ELDER are provided in Table 2 for comparison [9]. In the original article, Table S1 was published with some errors. The correct Table S1 is given below.

Original language	English
Pages (from-to)	2801-2805
Number of pages	5
Journal	Diabetes Therapy
Volume	12
Issue number	10
DOIs	https://doi.org/10.1007/s13300-021-01134-7
State	Published - 2021/10

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s13300-021-01134-7

Fingerprint

Dive into the research topics of 'Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)'. Together they form a unique fingerprint.

Cite this

Nakamura, I., Maegawa, H., Tobe, K., & Uno, S. (2021). Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w). Diabetes Therapy, 12(10), 2801-2805. https://doi.org/10.1007/s13300-021-01134-7

@article{0ae14e950a6045558dea8ab33b2ae69b,

title = "Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)",

abstract = "In the original article, ADR data from STELLAELDER are provided for Table 3 incorrectly which is originally for Table 2. RESULTS Safety Original ADR data from STELLA-ELDER are provided in Table 3 for comparison [9]. Corrected ADR data from STELLA-ELDER are provided in Table 2 for comparison [9]. In the original article, Table S1 was published with some errors. The correct Table S1 is given below.",

author = "Ichiro Nakamura and Hiroshi Maegawa and Kazuyuki Tobe and Satoshi Uno",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = oct,

doi = "10.1007/s13300-021-01134-7",

language = "英語",

volume = "12",

pages = "2801--2805",

journal = "Diabetes Therapy",

issn = "1869-6953",

publisher = "Springer Publishing Company",

number = "10",

}

Nakamura, I, Maegawa, H, Tobe, K & Uno, S 2021, 'Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)', Diabetes Therapy, vol. 12, no. 10, pp. 2801-2805. https://doi.org/10.1007/s13300-021-01134-7

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w). / Nakamura, Ichiro; Maegawa, Hiroshi; Tobe, Kazuyuki et al.
In: Diabetes Therapy, Vol. 12, No. 10, 10.2021, p. 2801-2805.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM (Diabetes Therapy, (2021), 12, 5, (1359-1378), 10.1007/s13300-021-01042-w)

AU - Nakamura, Ichiro

AU - Maegawa, Hiroshi

AU - Tobe, Kazuyuki

AU - Uno, Satoshi

PY - 2021/10

Y1 - 2021/10

N2 - In the original article, ADR data from STELLAELDER are provided for Table 3 incorrectly which is originally for Table 2. RESULTS Safety Original ADR data from STELLA-ELDER are provided in Table 3 for comparison [9]. Corrected ADR data from STELLA-ELDER are provided in Table 2 for comparison [9]. In the original article, Table S1 was published with some errors. The correct Table S1 is given below.

AB - In the original article, ADR data from STELLAELDER are provided for Table 3 incorrectly which is originally for Table 2. RESULTS Safety Original ADR data from STELLA-ELDER are provided in Table 3 for comparison [9]. Corrected ADR data from STELLA-ELDER are provided in Table 2 for comparison [9]. In the original article, Table S1 was published with some errors. The correct Table S1 is given below.

UR - http://www.scopus.com/inward/record.url?scp=85113932470&partnerID=8YFLogxK

U2 - 10.1007/s13300-021-01134-7

DO - 10.1007/s13300-021-01134-7

M3 - コメント/討論

C2 - 34463953

AN - SCOPUS:85113932470

SN - 1869-6953

VL - 12

SP - 2801

EP - 2805

JO - Diabetes Therapy

JF - Diabetes Therapy

IS - 10

ER -